IGF2BP3 and acute myeloid leukemia: Functional recovery experiments showed that overexpression of SENP1 could reverse the effect of silencing IGF2BP3 on the proliferation, anti-apoptosis, and AKT pathway activities of AML cells (Fig. 8C-F).